BIOSENSE LABORATORIES AS

5006 BERGEN

Finances

Share Ownership

Return on Equity

−14,17 %

Current Ratio

4,58

Debt-to-Equity Ratio

Key figures (NOK)	2022	2021	2020	2019
Revenue	4 963 000	7 148 000	6 045 000	4 131 000
Net Income	−487 000	1 355 000	1 048 000	499 000
Total Assets	4 058 000	5 314 000	3 821 000	2 457 000
Total Equity	3 437 000	3 923 000	2 569 000	1 521 000

Income (NOK)	2022	2021	2020	2019
Revenue	4 963 000	7 148 000	6 045 000	4 131 000
Expenditure	5 545 000	5 773 000	5 046 000	3 633 000
Operating Profit	−582 000	1 374 000	998 000	498 000
Financial Income	175 000	98 000	191 000	50 000
Financial Costs	79 000	118 000	141 000	48 000
Financial Balance	96 000	−20 000	50 000	2 000
Earnings Before Tax	−487 000	1 355 000	1 048 000	499 000
Tax	0	0	0	0
Net Income	−487 000	1 355 000	1 048 000	499 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	1 209 000	1 387 000	126 000	57 000
Total Current Assets	2 849 000	3 927 000	3 695 000	2 400 000
Total Assets	4 058 000	5 314 000	3 821 000	2 457 000
Total Retained Equity	2 387 000	2 874 000	1 519 000	471 000
Total Equity	3 437 000	3 923 000	2 569 000	1 521 000
Total Long-Term Debt	0	0	0	0
Total Current Debt	622 000	1 391 000	1 252 000	936 000
Total Equity and Debt	4 058 000	5 314 000	3 821 000	2 457 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	4 951 000	7 148 000	6 045 000	4 131 000
Other Income	12 000	0	0	0
Revenue	4 963 000	7 148 000	6 045 000	4 131 000
Cost of Goods Sold	1 683 000	1 979 000	1 811 000	1 410 000
Salary Costs	2 764 000	2 706 000	2 090 000	1 446 000
Depreciation	168 000	65 000	14 000	3 000
Impairment	0	0	0	0
Expenditure	5 545 000	5 773 000	5 046 000	3 633 000
Operating Profit	−582 000	1 374 000	998 000	498 000
Financial Income	175 000	98 000	191 000	50 000
Financial Costs	79 000	118 000	141 000	48 000
Financial Balance	96 000	−20 000	50 000	2 000
Dividends	0	0	0	0
Net Income	−487 000	1 355 000	1 048 000	499 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	0	0	0	0
Real Eastate	0	0	0	0
Machinery and Plant Facilities	0	0	0	0
Fixtures	1 209 000	1 377 000	112 000	38 000
Total Tangible Assets	1 209 000	1 377 000	112 000	38 000
Total Fiancial Fixed Assets	0	9 000	14 000	19 000
Total Fixed Assets	1 209 000	1 387 000	126 000	57 000
Stock	560 000	362 000	125 000	223 000
Total Investments	0	0	0	0
Cash, Bank	1 831 000	2 796 000	2 997 000	1 648 000
Total Current Assets	2 849 000	3 927 000	3 695 000	2 400 000
Total Assets	4 058 000	5 314 000	3 821 000	2 457 000
Total Equity	3 437 000	3 923 000	2 569 000	1 521 000
Short-Term Group Debt	0	0	0	0
Total Long-Term Debt	0	0	0	0
Creditors	169 000	559 000	539 000	166 000
Unpaid Taxes	159 000	241 000	166 000	126 000
Dividends	0	0	0	0
Other Current Debt	293 000	590 000	547 000	644 000
Total Current Debt	622 000	1 391 000	1 252 000	936 000
Total Equity and Debt	4 058 000	5 314 000	3 821 000	2 457 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−14,17 %	34,54 %	40,79 %	32,81 %
Debt-to-Equity Ratio	0	0	0	0
Operating Profit Margin	−11,73 %	19,22 %	16,51 %	12,06 %
Current Ratio	4,58	2,82	2,95	2,56
Quick Ratio	45,95	3,82	3,28	3,37
Equity Ratio	0,85	0,74	0,67	0,62
Gross Profit Margin	66,09 %	72,31 %	70,04 %	65,87 %